Signpath Pharma Inc
SignPath Pharma is a clinical stage biotechnology company (Delaware C Corp.) founded in 2006. Currently, SignPath is actively developing products to treat cancer and mitigate drug-induced cardiac arrhythmia, which is a serious and common side effect of many drugs, and heart muscle damage caused by chemotherapy.
7-day free trial · no credit card
Verified contacts
5
available on Kipplo
LinkedIn employees
11
1 to 10 range
Open roles
—
no listings
Distinct roles
5
indexed titles
Tech stack
0
tools in use
Monthly traffic
21
organic / mo
Sign up free to see all 5 verified contacts at Signpath Pharma Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
5 contacts with verified email or phone · masked until revealed.
- MC
Michelle Comas
Vice President, Regulatory Affairs and Operations · Legal
EmailPhone - JP
Jonathan Plehn
Chief Medical Officer · Healthcare & Human Services
EmailPhone - KL
Kai Larson
President and CEO · General Business & Management
EmailPhone - PC
Pete Childs
Senior Vice President, Chief Financial Officer · Other
EmailPhone - TR
Timothy R. Touloukian
Senior Vice President Business Development · General Business & Management
EmailPhone
Showing 5 of 5 verified contacts
Top roles at Signpath Pharma Inc
5 distinct titles indexed · top 5 shown.
- 1chief medical officer
- 1president and ceo
- 1senior vice president business development
- 1senior vice president, chief financial officer
- 1vice president, regulatory affairs and operations
Sign up to unlock all 5 contacts at Signpath Pharma Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 5 verified contacts at Signpath Pharma Inc
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.